Jenburkt Pharmaceuticals Limited (BOM:524731)

Jenburkt Pharmaceuticals Revenue

Jenburkt Pharmaceuticals had revenue of 455.58M INR in the quarter ending September 30, 2025, with 10.53% growth. This brings the company's revenue in the last twelve months to 1.59B, up 7.27% year-over-year. In the fiscal year ending March 31, 2025, Jenburkt Pharmaceuticals had annual revenue of 1.52B with 6.85% growth.

• Revenue (ttm): 1.59B
• Revenue Growth: +7.27%
• P/S Ratio: 2.85
• Revenue / Employee: 2.04M
• Employees: 779
• Market Cap: 4.53B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	1.52B	97.25M	6.85%
Mar 31, 2024	1.42B	52.17M	3.82%
Mar 31, 2023	1.37B	127.69M	10.30%
Mar 31, 2022	1.24B	146.86M	13.44%
Mar 31, 2021	1.09B	-95.97M	-8.07%